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Mobile health (mHealth) apps have the potential to rev-
olutionize how patients self-manage diseases. A mobile 
resource that provides relevant information regard-
ing nutritional options and physician recommenda-
tions would be immensely beneficial in helping patients, 
particularly with chronic kidney disease (CKD), pre-
vent medical complications and slow their disease 
progression.
Given how powerful a tool mHealth apps could be for 
CKD patients, two app platforms (Apple and Google 
Play Stores) were searched to evaluate the quality of 
on-the-market apps. Using search terms such as “CKD,” 
“kidney nutrition,” and “diet CKD,” this study found 
3,204 apps. Omission criteria mentioned in the figure 1 
were then applied, leaving 14 apps.
These apps were then evaluated based on their features to 
determine benefits and shortcomings, overall evaluating 
their quality. These features included the ability of the 
app to track nutritional intake, adhere to the latest nutri-
tional guidelines, offer recipes, store clinician-accessible 
data, and provide CKD stage-specific recommendations 
in dietary intake.
While several existing apps met some of the criteria to 
be considered useful, it was concluded that an ideal app 
does not currently exist. Furthermore, notable shortcom-
ings to aid in the definition of an ideal mobile health app 
for CKD patients were established.
Flow diagram identifying CKD dietary apps of interest.
Research advisor Allon Friedman writes: “ I was impressed 
at how the project team tackled this important research 
question. I expect they learned a lot about what a research 
project entails and how to publish their findings. The 
results of their effort will have important implications for 
people with kidney disease around the world.”
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